Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

The comparative actions of inhaled leukotriene C4 (LTC4), leukotriene D4 (LTD4), and histamine were studied in six normal subjects. LTC4 and LTD4 were shown to be more potent bronchoconstrictors than histamine, with a more sustained action. LTC4 and LTD4 caused wheezing without cough or throat irritation and were shown to act on large and small airways.

[1]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[2]  E. R. Mcfadden,et al.  Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.

[3]  J. Gleason,et al.  In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig. , 1982, The Journal of pharmacology and experimental therapeutics.

[4]  Robert A. Lewis,et al.  Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.

[5]  E. Corey,et al.  Pharmacological activity of leukotrienes A4, B4, C4 and D4 on selected guinea-pig, rat, rabbit and human smooth muscles. , 1981, Prostaglandins and medicine.

[6]  M. Dixon,et al.  BRONCHOCONSTRICTION PRODUCED IN MAN BY LEUKOTRIENES C AND D , 1981, The Lancet.

[7]  P. Frith,et al.  Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. , 1981, The American review of respiratory disease.

[8]  R. Young,et al.  The synthesis of leukotrienes. , 1981, Progress in lipid research.

[9]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.

[10]  Robert A. Lewis,et al.  Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. , 1980, Biochemical and biophysical research communications.

[11]  E. Corey,et al.  Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Corey,et al.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Morris,et al.  Structure of slow-reacting substance of anaphylaxis from guinea-pig lung , 1980, Nature.

[14]  H. Morris,et al.  COMPARATIVE STUDIES ON IMMUNOLOGICALLY AND NON‐IMMUNOLOGICALLY PRODUCED SLOW‐REACTING SUBSTANCES FROM MAN, GUINEA‐PIG AND RAT , 1979, British journal of pharmacology.

[15]  N. Pride,et al.  Assessment of changes in airway calibre I. Tests of forced expiration. , 1979, British journal of clinical pharmacology.

[16]  E. R. Mcfadden,et al.  Localization and mechanisms of airway responses. , 1977, The New England journal of medicine.

[17]  K.,et al.  Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig. , 1974, The Journal of clinical investigation.

[18]  V. R. Hunt,et al.  Maximum expiratory flow rates in induced bronchoconstriction in man. , 1969, The Journal of clinical investigation.

[19]  P. Macklem,et al.  Significance of the relationship between lung recoil and maximum expiratory flow. , 1967, Journal of applied physiology.

[20]  J. H. Comroe,et al.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. , 1956, The Journal of clinical investigation.